News Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Delayed Nasdaq Other stock markets 11:32:56 26/06/2024 pm IST			5-day change	1st Jan Change
0.9301 ^USD	+3.33%		-2.46%	+69.11%

13/06	Xilio Therapeutics, Inc. Announces Board Appointments	CI
14/05	Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors	14/06	GL
Xilio Therapeutics, Inc. Announces Board Appointments	14/06	CI
Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results	14/05	GL
Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says	19/04	MT
Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/04	CI
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results	02/04	GL
Xilio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Sector Update: Health Care Stocks Slide Late Afternoon	02/04	MT
Top Midday Gainers	01/04	MT
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01/04	MT
Top Premarket Gainers	01/04	MT
Xilio Shares Take Flight Premarket After Gilead Deal	28/03	DJ
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall	28/03	MT
Xilio Therapeutics : Corporate Update Call	28/03	PU
Gilead Sciences Signs Exclusive Development, Commercialization License for Xilio's Tumor-Activated IL-12	28/03	MT
Transcript : Xilio Therapeutics, Inc. - Special Call	28/03
Xilio Therapeutics Plans Private Placement, Job Cuts	28/03	DJ
Gilead Sciences in Exclusive License for Xilio Tumor-Activated IL-12 Program	28/03	DJ
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing	28/03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Summary

Filters